SMAD3 and Peritoneal Fibrosis: Intraperitoneal administration of bone morphogenetic protein 7 inhibits peritoneal Smad3 expression and its phosphorylation, peritoneal fibrosis, inflammation, and angiogenesis in a chlorhexidine gluconate-treated model in uremic rats [102].